The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
- PMID: 10741697
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
Abstract
Breast cancers arising in carriers of mutations in the breast cancer susceptibility genes, BRCA1 and BRCA2, differ histologically from each other and from breast cancers unselected for a family history. However, a substantial proportion of families with multiple cases of breast cancer is not attributable to these two genes (non-BRCA1/2 families). We have now characterized the pathology of 82 breast cancers from non-BRCA1/2 families. Breast cancers in non-BRCA1/2 families were of lower grade (P = 0.0018), showed fewer mitoses (P < 0.0001), less nuclear pleomorphism (P = 0.0014), less lymphocytic infiltrate (P < 0.0001), a lesser extent of the tumor with a continuous pushing margin (P = 0.004), a lesser extent of the tumor composed of solid sheets of cells (P = 0.0047), less necrosis (P = 0.002), and wereparison with BRCA2 tumors, non-BRCA1/2 tumors were lower grade (P = 0.017) and exhibited less pleomorphism (P = 0.01) and more tubule formation (P = 0.05). In comparison with control breast cancers unselected for a family history of the disease, non-BRCA1/2 tumors were of significantly lower grade (P = 0.001), showed less pleomorphism (P = 0.0002), and had a lower mitotic count (P = 0.003). The results indicate that non-BRCA1/2 breast cancers differ histologically from both BRCA1 and BRCA2 breast cancers and are overall of lower grade. They also suggest that non-BRCA1/2 breast cancers differ from nonfamilial breast cancers, but these differences may be attributable to various types of bias.
Similar articles
-
Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.Lancet. 1997 May 24;349(9064):1505-10. Lancet. 1997. PMID: 9167459
-
BRCA-associated breast cancer: absence of a characteristic immunophenotype.Cancer Res. 1998 May 1;58(9):1839-42. Cancer Res. 1998. PMID: 9581822
-
Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3606-14. Clin Cancer Res. 2003. PMID: 14506147
-
Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. doi: 10.1006/gyno.2000.5861. Gynecol Oncol. 2000. PMID: 10985881 Review.
-
Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.J Clin Oncol. 2000 Nov 1;18(21 Suppl):107S-12S. J Clin Oncol. 2000. PMID: 11060337 Review.
Cited by
-
How many etiological subtypes of breast cancer: two, three, four, or more?J Natl Cancer Inst. 2014 Aug 12;106(8):dju165. doi: 10.1093/jnci/dju165. Print 2014 Aug. J Natl Cancer Inst. 2014. PMID: 25118203 Free PMC article. Review.
-
The contribution of inherited factors to the clinicopathological features and behavior of breast cancer.J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):453-65. doi: 10.1023/a:1014791115760. J Mammary Gland Biol Neoplasia. 2001. PMID: 12013534 Review.
-
Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.Cancer Prev Res (Phila). 2011 Jan;4(1):23-33. doi: 10.1158/1940-6207.CAPR-10-0212. Epub 2010 Oct 26. Cancer Prev Res (Phila). 2011. PMID: 20978112 Free PMC article.
-
Molecular and morphological analysis of adenoid cystic carcinoma of the breast with synchronous tubular adenosis.Virchows Arch. 2009 Jan;454(1):107-14. doi: 10.1007/s00428-008-0700-z. Epub 2008 Nov 25. Virchows Arch. 2009. PMID: 19031084
-
Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families.Oncotarget. 2017 Aug 12;8(45):78691-78712. doi: 10.18632/oncotarget.20219. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108258 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous